The clinical impact of prolonged steroid therapy in severe COVID-19 patients: a retrospective cohort study with propensity score matching
Prolonged steroid therapy beyond 10 days did not improve survival or other clinical outcomes in patients with severe COVID-19, suggesting that early steroid withdrawal may be appropriate for selected patients.
Authors
- Sang‐Oh Lee (ORCID: https://orcid.org/0000-0003-1381-8787)
- Ji‐Won Jung (ORCID: https://orcid.org/0000-0001-7044-4764)
- Jaijun Han (ORCID: https://orcid.org/0000-0002-6945-3310)
- Euijin Chang (ORCID: https://orcid.org/0000-0001-7417-0318)
- Sang‐Ho Choi (ORCID: https://orcid.org/0000-0002-4972-4531)
- Sung‐Han Kim (ORCID: https://orcid.org/0000-0002-6596-8253)
- Min Jae Kim (ORCID: https://orcid.org/0000-0002-5489-8608)
- Yang Soo Kim (ORCID: https://orcid.org/0000-0002-6785-8824)
- Yong Pil Chong (ORCID: https://orcid.org/0000-0003-1672-3185)
- Seongman Bae
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1186/s12890-025-03674-1
- Primary Topic
- Adrenal Hormones and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea